Ardent Health Partners, LLC
ARDT · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $5,966 | $5,409 | $5,130 | $4,870 |
| % Growth | 10.3% | 5.5% | 5.3% | – |
| Cost of Goods Sold | $1,033 | $141 | $955 | $927 |
| Gross Profit | $4,933 | $5,269 | $4,175 | $3,943 |
| % Margin | 82.7% | 97.4% | 81.4% | 81% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3,885 | $3,608 | $3,372 | $3,132 |
| SG&A Expenses | $3,885 | $3,623 | $3,372 | $3,132 |
| Sales & Mktg Exp. | $0 | $15 | $0 | $0 |
| Other Operating Expenses | $643 | $1,417 | $586 | $374 |
| Operating Expenses | $4,527 | $5,039 | $3,957 | $3,507 |
| Operating Income | $406 | $230 | $217 | $437 |
| % Margin | 6.8% | 4.2% | 4.2% | 9% |
| Other Income/Exp. Net | -$43 | -$78 | $94 | -$141 |
| Pre-Tax Income | $363 | $152 | $311 | $296 |
| Tax Expense | $63 | $23 | $46 | $51 |
| Net Income | $210 | $50 | $189 | $154 |
| % Margin | 3.5% | 0.9% | 3.7% | 3.2% |
| EPS | 1.59 | 0.35 | 1.32 | 1.08 |
| % Growth | 354.3% | -73.5% | 22.2% | – |
| EPS Diluted | 1.58 | 0.35 | 1.32 | 1.08 |
| Weighted Avg Shares Out | 132 | 143 | 143 | 143 |
| Weighted Avg Shares Out Dil | 133 | 143 | 143 | 143 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $66 | $65 | $82 | $94 |
| Depreciation & Amortization | $146 | $141 | $138 | $137 |
| EBITDA | $575 | $350 | $532 | $527 |
| % Margin | 9.6% | 6.5% | 10.4% | 10.8% |